According to its most recent report, the breakdown of states is:
- California: five confirmed, zero probable
- Conncticut: one confirmed, zero probable
- Florida: 24 confirmed, zero probable
- Georgia: one confirmed, zero probable
- Illinois: 227 confirmed, four probable
- Indiana: two confirmed, zero probable
- Maryland: five confirmed, zero probable
- Massachusetts: eight confirmed, zero probable
- New Jersey: 137 confirmed, 22 probable
- New York: 388 confirmed, four probable
- Oklahoma: two confirmed, zero probable
- Texas: five confirmed, zero probable
- Virginia: one confirmed, zero probable
The CDC said it considers C. auris a serious global health threat for three main reasons:
- It is often multidrug-resistant.
- It can be misidentified in labs without specific technology. Misidentification may lead to inappropriate management.
- It has caused outbreaks in health care settings. For this reason, it is important to quickly identify C. auris in a hospitalized patient so that health care facilities can take special precautions to stop its spread.
The CDC says that the spread of the fungus is worldwide:
- Single cases of C. auris have been reported from Austria, Belgium, Chile, Costa Rica, Greece, Italy, Iran, the Netherlands, Norway, Switzerland, Taiwan, Thailand, and the United Arab Emirates.
- Multiple cases of C. auris have been reported from Australia, Bangladesh, Canada, China, Colombia, France, Germany, India, Israel, Japan, Kenya, Kuwait, Malaysia, Oman, Pakistan, Panama, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, the United Kingdom, the United States (primarily from the New York City area, New Jersey, and the Chicago area) and Venezuela; in some of these countries, extensive transmission of C. auris has been documented in more than one hospital.
- U.S. cases of C. auris have been found in patients who had recent stays in health care facilities in India, Kenya, Kuwait, Pakistan, South Africa, the United Arab Emirates, and Venezuela, which also have documented cases.